Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[The Clinical Outcome of Conversion Surgery for Unresectable Gastric Cancers in Our Institution]Hisashi Gunji, Shinichi Sakuramoto, Kenichi Aratani, et al.
In Vivo (Athens, Greece)|March 1, 2020
Persistent Descending Mesocolon as a Key Risk Factor in Laparoscopic Colorectal Cancer SurgeryLiming Wang, Hiroka Kondo, Yasumitsu Hirano, et al.
In Vivo (Athens, Greece)|January 6, 2021
Impact of Lymphovascular Invasion in Patients With Stage II Colorectal Cancer: A Propensity Score-matched StudyMasahiro Kataoka, Yasumitsu Hirano, Toshimasa Ishii, et al.
Surgical Case Reports|October 7, 2020
Right hemicolectomy with D3 lymph node dissection for right-sided transverse colon cancer using the Senhance robotic system: a case reportAtsuko Kataoka, Yasumitsu Hirano, Hiroka Kondo, et al.
Hepato-Gastroenterology|November 26, 2011
A comparative study on the short-term clinical outcomes of laparoscopic versus open Hartmann's procedure for high risk patients in colorectal cancerJo Tashiro, Shigeki Yamaguchi, Toshimasa Ishii, et al.
Cancer Science|January 15, 2011
Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithmYoji Nakamura, Sachiko Tai, Chie Oshita, et al.
Anticancer Research|March 6, 2020
Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from JapanLiming Wang, Yasumitsu Hirano, Gregory Heng, et al.
Surgical Endoscopy|May 15, 2012
Short-term outcomes of laparoscopic intersphincteric resection from a phase II trial to evaluate laparoscopic surgery for stage 0/I rectal cancer: Japan Society of Laparoscopic Colorectal Surgery Lap RCShoichi Fujii, Seiichiro Yamamoto, Masaaki Ito, et al.
Journal of the American College of Surgeons|August 2, 2003
Magnitude of serosal changes predicts peritoneal recurrence of gastric cancerEtsuro Bando, Taichi Kawamura, Kazuo Kinoshita, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 24, 2022
Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 studyHidetoshi Shibahara, Takeru Shiroiwa, Megumi Ishiguro, et al.
Pageof 25